Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE887.1041.75 (+4.94 %)

PREV CLOSE ( ) 845.35

OPEN PRICE ( ) 887.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1392

TODAY'S LOW / HIGH ( )886.95 887.60

52 WK LOW / HIGH ( ) 7361016

NSE

This Company is not listed in NSE

Chairman	Sanjay Patel
Managing Director	Rajendra R Shah
Company Secretary	Krishna Shah
Promoter & Non-Executive Director	Dilip R Shah
Independent Non-Executive Director	Jayantilal Raval
Non Independent & Non Executive Director	Paresh Mistry Janki R Shah

Incorporation Year : 12-02 1982

Registered Office :

Address : 18, Shreeji Bhuvan,51, Mangaldas Road,Princess Street Mumbai,
Maharashtra-400002 .

Phone : 022 66372841 / 22015441

Industry : Pharmaceuticals & Drugs

Listing : BSE,OTCEI